We're making the next batch
Ships in ~7 days or less
These products are for laboratory research only and not intended for medical use. They must be handled by qualified professionals in controlled laboratory environments. This compound has not been evaluated by the FDA and is not approved for human or veterinary use.
This product is supplied as a lyophilized powder with purity ≥98% as determined by reverse-phase HPLC. Lot-specific certificates of analysis (CoA) including mass spectrometric confirmation of molecular identity are available upon request.
Published preclinical research on peptides of this class has employed standard in vitro systems, including receptor-expressing cell lines and general laboratory assay models. This material is supplied for in vitro laboratory research use only and is not intended for human or animal use.
GLP-2 acts as a co-agonist at the glucose-dependent insulinotropic polypeptide receptor (GIPR) and the glucagon-like peptide-1 receptor (GLP-1R), both members of the class B G protein-coupled receptor (GPCR) family. Receptor engagement activates adenylyl cyclase, elevating intracellular cAMP and initiating downstream PKA and EPAC-mediated signaling pathways.
No. This product is supplied strictly for in vitro laboratory research and preclinical studies. It is not approved, tested, or intended for human administration, clinical investigation, veterinary use, or any therapeutic application. Researchers are responsible for compliance with all applicable institutional and regulatory guidelines.
Quality controlled from start to finish. No outsourcing.
GLP-2 is a 39-amino-acid synthetic peptide with dual GIP and GLP-1 receptor binding activity and a C20 fatty di-acid moiety for extended duration. Supplied as a research reagent for in vitro laboratory assays only; not for human or animal use.
